Integrative genomics of microglia implicates DLG4 (PSD95) in the white matter development of preterm infants

Michelle L Krishnan1, Juliette Van Steenwinckel2,3, Anne-Laure Schang2,3

  • 1Centre for the Developing Brain, Department of Perinatal Imaging and Health, Division of Imaging Sciences and Biomedical Engineering, King's College London, King's Health Partners, St. Thomas' Hospital, London, SE1 7EH, UK.

Nature Communications
|September 7, 2017
PubMed

Insights

Microglia play a key role in preterm infant brain injury. Microglial DLG4 (PSD95) protein is involved in inflammation and brain development, impacting injury susceptibility.

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Immunology

Background:

  • Preterm birth creates an adverse environment, leading to abnormal infant brain development and injury.
  • Neuroinflammation, particularly involving microglia, is implicated in preterm white matter damage, but mechanisms remain unclear.

Purpose of the Study:

  • To investigate the role of microglia in preterm white matter damage.
  • To integrate human and mouse molecular and neuroimaging data to understand microglial involvement.

Main Methods:

  • Utilized a mouse model of prematurity encephalopathy induced by interleukin-1β.
  • Performed gene network analysis, protein-protein interaction analysis, and transcription factor analysis.
  • Analyzed human brain gene expression and used imaging genomics in preterm infants.

Main Results:

  • Identified DLG4 (PSD95) protein synthesis by microglia in immature mouse and human brains.
  • Found DLG4 to be developmentally regulated, modulated by inflammation, and a hub protein in the microglial inflammatory response.
  • Demonstrated that genetic variation in DLG4 is associated with structural differences in the preterm infant brain.

Conclusions:

  • Microglial DLG4 (PSD95) is involved in brain development and modulates susceptibility to injury after preterm birth.
  • DLG4 plays a significant role in the microglial inflammatory response within the context of preterm birth.
  • Findings highlight DLG4 as a potential therapeutic target for mitigating preterm birth complications.

Related Concept Videos